Department of Neurosurgery, Fukuoka Neurosurgical Hospital, Fukuoka Minami-ku, Fukuoka, Japan; Department of Neurosurgery, Saiseikai Noe Hospital, Osaka Joto-ku, Osaka, Japan; Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Department of Neurosurgery, Fukuoka Neurosurgical Hospital, Fukuoka Minami-ku, Fukuoka, Japan.
J Stroke Cerebrovasc Dis. 2022 Oct;31(10):106668. doi: 10.1016/j.jstrokecerebrovasdis.2022.106668. Epub 2022 Aug 18.
We are going to discuss about usefulness and problems of Y-stent and T-stent assisted coiling for unruptured cerebral aneurysms.
A retrospective review was performed to identify patients who were treated using Y-stent or T-stent assisted coiling (Y-SAC, T-SAC) for 25 unruptured cerebral aneurysms from April 2017 to September 2021. Fifteen cases were treated using Y-SAC, 10 were done using T-SAC. Only a case was treated with Low-profile Visualized Intraluminal Support (LVIS; MicroVention TRUMO, Aliso Viejo, California, USA) and Neuroform ATLAS (Striker, Kalamazoo, Michigan, USA), Others were done with two Neuroform ATLAS stents.
Y-SAC and T-SAC were succeeded in all cases. In two cases that were treated using Y-SAC, ischemic complications were observed. A patient received additional embolization because subarachnoid hemorrhage (SAH) was appeared after discharge. On follow-up imaging, complete occlusion (CO) was confirmed in all cases.
The position of deployment of stents was the most important issue. In particular, the second stent should be deployed as to contact the first stent, as possible. The case that the position of the second stent was shifted, and neck was not covered was observed. In the cases that are treated by using T-SAC, microcatheter must be navigated to distal position as possible. In that point, Y-SAC is more applicable. The familiarization of Y-SAC or T-SAC will expand the indication of endovascular treatment for unruptured cerebral aneurysms.
我们将讨论未破裂脑动脉瘤中 Y 支架和 T 支架辅助弹簧圈治疗的有效性和问题。
回顾性分析 2017 年 4 月至 2021 年 9 月期间采用 Y 支架或 T 支架辅助弹簧圈(Y-SAC、T-SAC)治疗的 25 例未破裂脑动脉瘤患者。15 例采用 Y-SAC 治疗,10 例采用 T-SAC 治疗。仅 1 例采用低轮廓可视化腔内支撑(LVIS;Microvention TRUMO,加利福尼亚州艾尔西诺湖,美国)和 Neuroform ATLAS(Striker,密歇根州卡拉马祖,美国)治疗,其余均采用 2 枚 Neuroform ATLAS 支架治疗。
Y-SAC 和 T-SAC 在所有病例中均成功。在采用 Y-SAC 治疗的 2 例病例中观察到缺血性并发症。1 例患者因出院后出现蛛网膜下腔出血(SAH)而接受了额外的栓塞治疗。随访影像学检查证实所有病例均完全闭塞(CO)。
支架的放置位置是最重要的问题。特别是,第二枚支架应尽可能接触第一枚支架进行放置。观察到第二枚支架的位置移位,颈未被覆盖的病例。在采用 T-SAC 治疗的病例中,微导管必须尽可能地向远端导航。在这点上,Y-SAC 更适用。对 Y-SAC 或 T-SAC 的熟悉将扩大未破裂脑动脉瘤血管内治疗的适应证。